Denice Torres
Known title: DirectorCIK: 0001820278
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Seaport Therapeutics Gains Analyst Attention Ahead of ECNP Data. Seaport Therapeutics has attracted new analyst coverage, with Canaccord Genuity and HC Wainwright both issuing price targets of $28 and $50 respectively. The company will present additional pharmacokinetic data from its Phase 1 GlyphAgo trial at the ECNP Congress in October. These developments add fresh information for investors to assess the drug’s progress. The stock remains near its 52‑week low, with a support level around $17.79.
Transaction History
| GKOS | ▲ Buy | Grant | 1,878 | $0 | 5/28/2026 | View on chart |
| SPTX | ▼ Sell | Other | 13,406 | — | 5/4/2026 | View on chart |
| GKOS | ▲ Buy | Grant | 623 | $0 | 1/2/2026 | View on chart |
| GKOS | ▲ Buy | Grant | 2,108 | $0 | 5/29/2025 | View on chart |
| GKOS | ▲ Buy | Grant | 461 | $0 | 1/2/2025 | View on chart |
| GKOS | ▲ Buy | Grant | 1,716 | $0 | 5/30/2024 | View on chart |
| GKOS | ▲ Buy | Grant | 895 | $0 | 1/2/2024 | View on chart |
| GKOS | ▲ Buy | Grant | 3,230 | $0 | 6/1/2023 | View on chart |
| GKOS | ▲ Buy | Grant | 1,572 | $0 | 1/3/2023 | View on chart |
| GKOS | ▲ Buy | Grant | 4,364 | $0 | 6/2/2022 | View on chart |
| GKOS | ▲ Buy | Grant | 1,455 | $0 | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
GKOS Joins Big Stocks Rising on Wednesday; 10‑Year Gains Highlight
GKOS was among the large stocks that gained on Wednesday, adding to its recent upward momentum. A Benzinga piece noted that a $1,000 investment in GKOS 10 years ago would be worth a substantial amount today, underscoring the company's long‑term growth. These stories highlight both the current price action and the company's historical performance.
GKOS Joins Big Stocks Rising on Wednesday; 10‑Year Gains Highlight. GKOS was among the large stocks that gained on Wednesday, adding to its recent upward momentum. A Benzinga piece noted that a $1,000 investment in GKOS 10 years ago would be worth a substantial amount today, underscoring the company's long‑term growth. These stories highlight both the current price action and the company's historical performance.